Ozempic Linked to 30% Lower Breast Cancer Risk
Beyond Weight Loss: The Emerging Role of GLP-1 Agonists in Cancer Prevention For millions, medications like Ozempic, Wegovy, Mounjaro, and Zepbound have become synonymous with the modern approach to weight management and diabetes care. However, a groundbreaking study presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting suggests these drugs may offer … Read more